BETHEL, Conn., May 13, 2011 /PRNewswire/ -- MedClean Technologies, Inc. (OTC Bulletin Board: MCLN), the leading providerof on-site technology for the treatment and disposal of medical waste and the destruction of confidential documents and related media, today announced it has formed a co-marketing agreement with Covidien, a leading global healthcare products company.
"This relationship is our largest co-promotion arrangement to date, broadening the exposure of our products and connecting MedClean with nearly every hospital in the country," commented David Laky, MedClean's President and CEO. "One of the goals of this co- promotion relationship is to ensure the market is educated about disposable sharps versus reusable sharps and the benefits, through safety and expense reduction, that disposable sharps programs provide to healthcare facilities. We estimate the market for sharps containers to exceed $280million annually, and capturing a significant share of this market is a priority for both companies. We are excited to collaborate with Covidien and look forward to a long and mutually productive relationship."
MedClean now has approximately 98 sales professionals in 50 states plus Canada promoting the Company's innovative Technology enabled Solutions (TeS) for the treatment and disposal of medical waste and the destruction of confidential documents and related media.
"The extended sales cycle and the process for educating sales professionals on the benefits and details of our systems takes about six to nine months," added Mr. Laky. "We continue to see distributors ramping up their lead generation efforts over this time frame, and as such we believe we will see an acceleration of our sales in the coming quarters due to the many relationships we have brought on board in the last year."
About MedClean Technologies, Inc.
MedClean Technologies, Inc. is a provider of innovative technology and services for the onsite treatment and disposal of regulated medical waste. MedClean's flagship MedClean® Series systems are fully integrated, turnkey technology solutions that enable hospitals and other healthcare providers to safely, efficiently, and cost-effectively convert bio-hazardous regulated medical waste into sterile, unrecognizable material suitable for disposal as municipal solid waste. MedClean was founded in 1997 with corporate headquarters, research and development and distribution facilities located in Bethel, Connecticut. Further information on MedClean can be found at www.medcleantechnologies.com and in filings with the Securities and Exchange Commission found at www.sec.gov.
Statements about our future expectations are "forward-looking statements" within the meaning of applicable Federal Securities Laws, and are not guarantees of future performance. When used herein, the words "may," "will," "should," "anticipate," "believe," "appear," "intend," "plan," "expect," "estimate," "approximate," "potential" and similar expressions are intended to identify such forward-looking statements. These statements involve risks and uncertainties inherent in our business; including those set forth in our most recent Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on March 3, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.
CONTACT: Cameron DonahueHayden IR (651) 653-1854
SOURCE MedClean Technologies, Inc.
Subscribe to our Free Newsletters!
Statins are a group of drugs which help to lower the blood cholesterol levels.
Niemann-Pick disease is a group of inherited metabolic disorders in which cholesterol and lipids ...
Raspberries are packed with important nutrients, vitamins and minerals. They help boost immunity, ...View All